We are live on
!
Find out more
CCM
Copeland Capital Management Portfolio holdings
AUM
$4.5B
1-Year Est. Return
18.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+18.67%
3 Year Est. Return
+43.33%
5 Year Est. Return
+60.9%
10 Year Est. Return
+320.99%
AUM
$1.44B
AUM Growth
-$102M
(-6.6%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-11.45%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
145
New
4
Increased
42
Reduced
81
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGOV
NIC Inc
EGOV
|
+$11.6M |
| 2 |
HBI
Hanesbrands
HBI
|
+$6.01M |
| 3 |
CVS Health
CVS
|
+$5.98M |
| 4 |
MarketAxess Holdings
MKTX
|
+$5.83M |
| 5 |
Constellation Brands
STZ
|
+$5.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pool Corp
POOL
|
+$15.8M |
| 2 |
Brinker International
EAT
|
+$14.2M |
| 3 |
Casey's General Stores
CASY
|
+$13.3M |
| 4 |
CEB
CEB Inc.
CEB
|
+$13.3M |
| 5 |
Altria Group
MO
|
+$7.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.52% |
| 2 | Financials | 15.16% |
| 3 | Healthcare | 13.24% |
| 4 | Technology | 12.65% |
| 5 | Consumer Discretionary | 12.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
AbbVie
ABBV
$443B
| $303K | 0.02% |
4,791
-465
| -9% | -$29.2K |
|
127
Pfizer
PFE
$143B
| $285K | 0.02% |
8,708
| – | – |
|
128
3M
MMM
$90.9B
| $284K | 0.02% |
1,794
| – | – |
|
129
McDonald's
MCD
$192B
| $246K | 0.02% |
1,925
-300
| -13% | -$37.6K |
|
130
Microsoft
MSFT
$3.45T
| $219K | 0.02% |
3,401
-400
| -11% | -$25.6K |
|
|
PSXP
131
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $215K | 0.02% |
3,891
-68,006
| -95% | -$3.63M |
|
132
APA Corp
APA
$13.2B
| $208K | 0.01% |
4,000
| – | – |
|
133
Digital Realty Trust
DLR
$69.7B
| $206K | 0.01% |
1,905
-425
| -18% | -$44.7K |
|
|
134
Brinker International
EAT
$9.17B
| – | – |
-286,981
| Closed | -$14.2M |
|
135
W.W. Grainger
GWW
$65.3B
| – | – |
-1,201
| Closed | -$279K |
|
136
iShares Russell 2000 ETF
IWM
$79.8B
| – | – |
-22,005
| Closed | -$2.97M |
|
137
Mastercard
MA
$506B
| – | – |
-40,480
| Closed | -$4.18M |
|
138
Parker-Hannifin
PH
$123B
| – | – |
-1,500
| Closed | -$210K |
|
139
Polaris
PII
$3.82B
| – | – |
-56,006
| Closed | -$4.61M |
|
140
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-12,584
| Closed | -$456K |
|
141
VF Corp
VFC
$5.63B
| – | – |
-12,051
| Closed | -$605K |
|
|
VAL
142
DELISTED
Valspar
VAL
| – | – |
-8,827
| Closed | -$915K |
|
|
BEAV
143
DELISTED
B/E Aerospace Inc
BEAV
| – | – |
-97,231
| Closed | -$5.85M |
|
|
CEB
144
DELISTED
CEB Inc.
CEB
| – | – |
-219,406
| Closed | -$13.3M |
|
|
SE
145
DELISTED
Spectra Energy Corp Wi
SE
| – | – |
-77,584
| Closed | -$3.19M |
|
Similar funds
JRP
DK
GIBU
IC
SCM
SV
CAU
LNWTC
Copeland Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Copeland Capital Management held 145 positions worth $1.44B, down 6.6% from $1.54B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Copeland Capital Management withdrew a net $165M in Q1 2017, closing 12 positions and reducing 81 holdings. Its most notable exit was Brinker International, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Copeland Capital Management opened a new position in NIC Inc worth $10.9M.
- Copeland Capital Management's largest Q1 2017 buy was NIC Inc: 517,837 shares worth $10.9M.
- Copeland Capital Management added most to CVS Health in Q1 2017, an estimated $5.98M increase.
- Copeland Capital Management's biggest Q1 2017 reduction was Pool Corp, cutting an estimated $15.8M.
- Copeland Capital Management fully exited Brinker International in Q1 2017, selling an estimated $14.2M.
- Copeland Capital Management's ten largest holdings make up 20% of its $1.44B portfolio in Q1 2017.
- Copeland Capital Management opened 4 new positions and closed 12 in Q1 2017.
- Copeland Capital Management's portfolio value fell 6.6% quarter-over-quarter to $1.44B.
Based on Copeland Capital Management's 13F filing for Q1 2017, filed 2 May 2017.